Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Barringer Technologies completes $750,000 private placement.


NEW PROVIDENCE, N.J.--(BUSINESS WIRE)--May 12, 1995--Barringer Technologies Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:BARR BARR Board on Agriculture and Renewable Resources (Washington, DC, USA)
BARR Bureau of Aeronautics Resident Representative
, BARRW) today announced that it had completed a private sale of 125 units to two institutional investors at a purchase price of $6,000 per unit for an aggregate purchase price of $750,000.

Each unit consists of 10,000 shares of common stock and a five-year warrant to purchase 10,000 shares of the company's common stock at 50 cents per share Cents per share

The amount of a mutual fund's dividend or capital gains distributions that a shareholder will receive for each share owned.
, subject to certain anti-dilutive provisions. As an inducement to enter into the transaction and in lieu of a transaction fee, a three-year warrant to purchase 150,000 of the company's common stock at 50 cents per share, subject to certain anti-dilutive provisions, was issued to the purchasers.

Stanley Binder, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , stated that "the company will use the net proceeds for working capital purposes, principally for manufacturing our new Model 400 IONSCAN(R) and related sales and promotional expenses as well as earmarking $150,000 of the proceeds to develop a sales, marketing and operational infrastructure to support sales of our new in-home drug detection and identification kit marketed under the name DrugAlert." Binder indicated that the company expects to raise additional funds in the near future.

Headquartered in New Providence, Barringer Technologies Inc., is a holding company with three operating groups. Barringer Instruments develops, manufactures and markets specialty analytical instruments for drugs and explosives detection, exploration and environmental monitoring applications. Barringer Consumer Products markets an in-home drug detection and identification kit. Barringer Laboratories Inc. (OTC OTC

See: Over-the-counter.


OTC

See over-the-counter market (OTC).
 Symbol:BALB BALB Bagg Albino (inbred research mouse strain) ), which is 47% owned by the company, provides analytical services for the environmental and mineral industries.

CONTACT: Barringer Technologies Inc.

Stanley Binder or Richard S. Rosenfeld,

908/665-8200
COPYRIGHT 1995 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1995, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:May 12, 1995
Words:281
Previous Article:Federally-chartered Sallie Mae supports legislation to convert the corporation to fully private status.
Next Article:Royal Bank, CIBC introducing Mondex electronic cash system to North America.
Topics:



Related Articles
Barringer Technologies files preliminary proxy materials; Completes private placement.
Barringer Announces DRUGALERT Distribution Agreement With Unilabs Holdings S.A. Affiliate.
Barringer Technologies announces first quarter results.
Barringer Technologies announces second quarter results.
Barringer Technologies stockholders approve increase in authorized common stock.
Barringer Technologies Announces Record Fourth Quarter and Year-End Results.
Barringer Technologies Inc. Announces Exercise of Over-Allotment Option by Underwriting Syndicate.
Barringer Technologies Inc. Announces Second Quarter 1998 Results.
SANTA CLARITA MOTHER, CHILDREN TAKE STAND FOR SIDEWALKS, SAFETY : U.S. LOAN NEEDED TO SPEED PROGRAM.
BioSante Pharmaceuticals Reports Second Quarter 2006 Financial Results.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles